Choose ONE of the following ICU illness severity scoring systems:
1. Australian and New Zealand Risk of Death (ANZROD) or
2. Acute Physiology and Chronic Health Evaluation (APACHE) III/IV
For your chosen scoring system:
a) List the key components. (2 marks)
b) Outline the current applications / usage in intensive care. (5 marks)
c) List the limitations of your chosen illness severity scoring system. (3 marks)
Syllabus topic/section:
2.1.2 Decision Making: Severity scoring and outcome prediction: L1
Discussion:
This question focused on the core topic of ICU scoring systems. We recommend that candidates have good knowledge of the principles and details of common ICU severity scoring systems. The question was generally answered well if candidates took a broad approach.
Part a) required a list of the key components (acute physiological scores, age and chronic health conditions) rather than an extensive list of the individual acute physiological components. Many candidates missed simple marks by not mentioning the 24-hour timeframe for the data acquisition of the physiological scores or the impact of relevant chronic conditions.
Part b) was answered well if candidates provided a detailed outline of several applications rather than a superficial list. Candidates also did well if they used broad headings (safety and quality, clinical or research for example) and then added detail with subheadings to ensure they included a breadth of applications. Please note the glossary terms outline vs list.
Part c) required a simple list, and candidates scored well if they could provide several limitations. The marking rubric is included to aid the candidate’s future study.
|
Below standard |
At standard |
Above standard |
|
|
a) Key Components |
Only included 0-2 components or didn’t recognise that physiology scores are within 24 hours of ICU admission or included incorrect components |
Included all 3 components and noted physiology should be within 24 hours. Also included some detail around chronic health conditions or the physiological variables |
At standard plus Included all 3 components plus some detail around chronic health conditions and physiological variables. Also included some of the info specific to the chosen scoring system to score full marks |
|
(2 marks) |
0-0.5 marks |
1 mark |
1.5 - 2 marks |
|
b) Current Applications/ Clinical Usage |
Recognises a couple of applications with some detail to each OR Superficial knowledge of 3 different areas |
Demonstrates sound knowledge of the applications with an understanding of most of the components listed. Does not need to include all 4 areas but understands that they are used in benchmarking, outcome prediction and research |
Demonstrates advanced knowledge of applications with good detail. Coverage of ALL applications is not required for advanced marks, but should be a broad range across the categories with good understanding demonstrated |
|
(5 marks) |
0-2 marks |
2.5-3.5 marks |
4-5 marks |
|
c) Limitations |
Only a couple of limitations are identified, or incorrect factors are included |
A reasonable number of limitations are identified with minimal detail included |
Majority of the limitations are identified with some detail included |
|
(3 marks) |
0-1 mark |
1.5-2 marks |
2.5-3 marks |
We have been here before. Question 11 from the first paper of 2009 asked the candidates to compare APACHE with SOFA, and Question 4 from the second paper of 2005 asked about the principles of scoring systems in general. And then, when examiners asked about scoring systems in Question 18 from the cursed first paper of 2023, whereas the intention was clearly to get answers about APACHE and SOFA, some candidates wrote about the GCS and the Child-Pugh score, which actually answered the question, and had to be marked. The specific choices offered to the candidates in this sitting appear to be a deliberate effort to guide them towards a specific answer.
What follows is a repurposed answer from Question 18. APACHE-IIIj is used here mostly because it is very similar to APACHE IV (only a couple of extra things were added, and the disease-specific coefficients have been updated to change the calculated risk). ANZROD is also basically APACHE IIIj with some adjustments to the weights, to reflect that the American critical care mortality is higher than Australian.
Components of APACHE III-j
Advantages of APACHE III-j
Applications of APACHE III-j in the ICU
Limitations of APACHE III-j
A lot of these advantages and disadvantages were extracted from the excellent 2008 paper by Shann et al.
Paul, Eldho, et al. "The ANZROD model: better benchmarking of ICU outcomes and detection of outliers." Critical care and resuscitation 18.1 (2016): 25-36.
Paul, E., et al. "Assessing contemporary intensive care unit outcome: development and validation of the Australian and New Zealand risk of death admission model." Anaesthesia and intensive care 45.3 (2017): 326-343.